When a cocaine addict relapses, it isn’t a matter of personal failure – it’s the biological result of their brain’s rewiring, new research finds.
Michigan State University scientists found that cocaine changes how the hippocampus…

When a cocaine addict relapses, it isn’t a matter of personal failure – it’s the biological result of their brain’s rewiring, new research finds.
Michigan State University scientists found that cocaine changes how the hippocampus…

This Plain language summary of publication article, published in Future Oncology, provides a breakdown of the strategies used in the MajesTEC-1 study to manage side effects that may occur with teclistamab treatment.
Access the full…

Professor Chris Twelves, clinical director at the Leeds Teaching Hospitals NHS Trust NIHR Leeds CRF and Professor of Clinical Cancer Pharmacology and Oncology at the University of Leeds said: “This investigational cancer vaccine works by training…
SINGAPORE, March 5 (Xinhua) — Singapore will introduce an artificial intelligence (AI) assessment tool in early 2027 to help identify individuals at high risk for cardiovascular disease, the Ministry of Health said Thursday.
Developed by…
Jebari-Benslaiman, S. et al. Pathophysiology of Atherosclerosis. Int. J. Mol. Sci. 23 https://doi.org/10.3390/ijms23063346 (2022).
Bergstrom, G. et al. Prevalence of subclinical coronary Artery atherosclerosis in the general population….

Attention-deficit/hyperactivity disorder (ADHD) is often talked about as if it were a single condition. But anyone who works with children with ADHD-or raises one-knows that symptoms can look very different from one child to…

Researchers at the Johns Hopkins Kimmel Cancer Center report that an artificial intelligence (AI)-based liquid biopsy test using genome-wide cell-free DNA (cfDNA) fragmentation patterns and repeat landscapes can detect early liver…

Gov.UK New targeted trial in turkeys will test vaccine efficacy as part of fight to protect wild and captive birds. Highly pathogenic avian influenza (HPAI) vaccine trials have started…